Home   About this service   Get the news  
+32 2 743 34 03

 
UCB [BE0003739530 / UCB]

UCB Media Room: Disposals of own shares

INFORMATION REGLEMENTEE


[04/06/2021 | 20:05]
https://mb.cision.com/Public/18595/logo/86a99b25f755738d_org.jpg

** Disposals of own shares
------------------------------------------------------------

Brussels (Belgium), 4 June 2021 =E2=80=93 20:00 (CEST) =E2=80=93 regulated =
information

Disposal of own shares

In accordance with article 8:6 of the Royal Decree executing the Belgian Co=
de of Companies and Associations, UCB announces that, following exercises o=
f stock options by members of its personnel, it has disposed of UCB shares =
OTC in view of deliveries of these shares to the relevant members of the pe=
rsonnel, within the framework of the Long Term Incentive Program of the UCB=
Group, as follows:

https://mb.cision.com/Public/18595/3361438/81430b0ecac00190_800x800ar.png
=C2=A0
In addition to these exercises, on 1 June 2021, in accordance with its Stoc=
k Award Plan 2020, UCB SA/NV has delivered for free 106 UCB shares OTC to o=
ne member of the personnel of the Company and its subsidiaries. The highest=
independent bid price on Euronext Brussels on 1 June 2021 was =E2=82=AC77,=
00.
This press release is available on UCB SA/NV=E2=80=99s website via the foll=
owing link (https://www.ucb.com/stories-media/Press-Releases) .

Investor Relations
Antje Witte =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0
Investor Relations, UCB
T +32.2.559.94.14 antje.witte@ucb.com

About UCB

UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company =
focused on the discovery and development of innovative medicines and soluti=
ons to transform the lives of people living with severe diseases of the imm=
une system or of the central nervous system. With approximately 8 400 peopl=
e in nearly 40 countries, the company generated revenue of =E2=82=AC 5.3 bi=
llion in 2020. UCB is listed on Euronext Brussels (symbol: UCB). Follow us =
on Twitter: @UCB_news

GenericFile
210604 - Disposals of own shares ENG final (https://mb.cision.com/Public/18=
595/3361438/bfcc98218179468a.pdf) GenericFile
210604- Vervreemding van eigen aandelen NED (https://mb.cision.com/Public/1=
8595/3361438/874a5bf32f70e143.pdf) GenericFile
210604- Ali=C3=A9nation d actions propres FR (https://mb.cision.com/Public/=
18595/3361438/8ff90938fcd496f5.pdf) Image
Chart 1 June 4 2021 (https://mb.cision.com/Public/18595/3361438/81430b0ecac=
00190_org.png)

______________________
If you would rather not receive future communications from UCB SA, please g=
o to https://eu.vocuspr.com/OptOut.aspx?2973226x20421x72164x1x6868579x24000=
x6&Email=3Dregnews%40symexglobal.com.
UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium